764 results on '"van Pesch, Vincent"'
Search Results
2. A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
3. Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination
4. Long-term follow up of alemtuzumab-treated patients: a retrospective study in a Belgian tertiary care center
5. Anti-NMDA-receptor encephalitis, a challenging case leading to the discovery of a rapidly growing tumor
6. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
7. Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global Community
8. Usefulness of serum neurofilament light in the assessment of neurologic outcome in the pediatric population: a systematic literature review
9. Influence of a pro-inflammatory stimulus on the miRNA and lipid content of human dental stem cell-derived extracellular vesicles and their impact on microglial activation
10. Longitudinal modeling of MS patient trajectories improves predictions of disability progression
11. MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators
12. Alzheimer disease’s cerebrospinal fluid biomarkers differences between immigrants and natives in a Belgian memory clinic
13. Patient-reported outcome measurements in a selective cohort of relapsing–remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment, and MRI-derived metrics
14. Cognitive trajectories in relapsing-remitting multiple sclerosis: Evidence of multiple evolutionary trends
15. B cell depletion therapy does not resolve chronic active multiple sclerosis lesions
16. Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis
17. EEG Responses to Upper Limb Pinprick Stimulation in Acute and Early Subacute Motor and Sensorimotor Stroke
18. Diagnosis and classification of optic neuritis
19. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
20. Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom
21. Phosphorylated tau 181 (p-tau181) as an innovative, fast and robust biomarker for cerebrospinal fluid leaks.
22. Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies
23. Reliability and External Validity of Digital Passive Gait Tracking in MS (P6-6.008)
24. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
25. Évolution des troubles cognitifs dans la SEP : des trajectoires hétérogènes ?
26. Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry
27. MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
28. Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer’s disease diagnosis: a retrospective study in a Belgian academic hospital
29. Bing–Neel syndrome hidden by multiple sclerosis, a challenging overlay of diseases
30. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
31. Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination.
32. Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients
33. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients
34. Enlarged perivascular spaces are associated with brain microangiopathy and aging in multiple sclerosis.
35. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
36. Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study
37. Paraneoplastic encephalomyelitis revealing burned-out seminoma
38. Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
39. Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
40. Comment on “Paraneoplastic encephalomyelitis revealing burned-out seminoma”: confirmed case of anti-Kelch-like protein-11 encephalomyelitis
41. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
42. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
43. Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
44. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting
45. Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis
46. Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a
47. Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients
48. Premotor dorsal white matter integrity for the prediction of upper limb motor impairment after stroke
49. CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders
50. Herpes simplex encephalitis relapse associated with positive N-methyl-d-aspartate receptor antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.